# Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adalimumab-for-severe-psoriasis-and-psoriatic-arthritis-an-open-label-study-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marina Papoutsaki,Maria Sole Chimenti,Antonio Costanzo,Marina Talamonti,Arianna Zangrilli,Alessandro Giunta,Luca Bianchi,Sergio Chimenti |
| Citations | 124 |
| DOI | 10.1016/j.jaad.2006.12.003 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2109304329 |
| PMID | 17574299 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Luca Bianchi](https://scholariq.org/researchers/luca-bianchi/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.